Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Munain, Adolfo López de"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Erratum to ‘Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia’ [Neuromuscular Disorders 19 (2009) 316–323]
Autorzy:
Stojkovic, Tanya
Hammouda, El Hadi
Richard, Pascale
Munain, Adolfo López de
Ruiz-Martinez, Javier
Camaño, Pilar
Laforêt, Pascal
Pénisson-Besnier, Isabelle
Ferrer, Xavier
Lacour, Arnaud
Lacomblez, Lucette
Claeys, Kristl G.
Maurage, Claude-Alain
Fardeau, Michel
Eymard, Bruno
Pokaż więcej
Źródło:
In Neuromuscular Disorders March 2011 21(3):e1-e1
Czasopismo naukowe
Tytuł:
Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease Patients.
Autorzy:
González-Sánchez M; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Jiménez J; Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering, University of Alcalá, 28871 Alcalá de Henares, Spain.
Narváez A; Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering, University of Alcalá, 28871 Alcalá de Henares, Spain.
Antequera D; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Llamas-Velasco S; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Martín AH; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Arjona JAM; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Munain AL; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.; Neurosciences Research Area, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.
Bisa AL; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.; Neurology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Marco MP; Nanobiotechnology for Diagnostics (Nb4D) Group, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), 08034 Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08034 Barcelona, Spain.
Rodríguez-Núñez M; Nanobiotechnology for Diagnostics (Nb4D) Group, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), 08034 Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08034 Barcelona, Spain.
Pérez-Martínez DA; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Villarejo-Galende A; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Bartolome F; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Domínguez E; Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering, University of Alcalá, 28871 Alcalá de Henares, Spain.
Carro E; Group of Neurodegenerative Diseases, Hospital 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2020 Apr 08; Vol. 10 (4). Date of Electronic Publication: 2020 Apr 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Kynurenic Acid/*cerebrospinal fluid
Aged ; Alzheimer Disease/metabolism ; Case-Control Studies ; Female ; Humans ; Kynurenic Acid/metabolism ; Male ; Middle Aged ; Tryptophan/cerebrospinal fluid ; Tryptophan/metabolism
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies